send mail to support@abhimanu.com mentioning your email id and mobileno registered with us! if details not recieved
Resend Opt after 60 Sec.
By Loging in you agree to Terms of Services and Privacy Policy
Claim your free MCQ
Please specify
Sorry for the inconvenience but we’re performing some maintenance at the moment. Website can be slow during this phase..
Please verify your mobile number
Login not allowed, Please logout from existing browser
Please update your name
Subscribe to Notifications
Stay updated with the latest Current affairs and other important updates regarding video Lectures, Test Schedules, live sessions etc..
Your Free user account at abhipedia has been created.
Remember, success is a journey, not a destination. Stay motivated and keep moving forward!
Refer & Earn
Enquire Now
My Abhipedia Earning
Kindly Login to view your earning
Support
Context: Recently, anti-malarial drug hydroxychloroquine has been notified under Schedule-H1 by the government. This was done in exercise of its powers conferred by Section 26B of the Drugs and Cosmetics Act, 1940 (23 of 1940). About Schedule-H1 Drug
As per government notification, these drugs are required to be sold in the country with the following conditions:
Implications of the classification of the malaria drug as Scheduled-H1
Classification of drugs in India based on their approval status are as follows
By: Shubham Tiwari ProfileResourcesReport error
Access to prime resources